Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CBLB [correction of CLBL] genes.

Varadé J, Comabella M, Ortiz MA, Arroyo R, Fernández O, Pinto-Medel MJ, Fedetz M, Izquierdo G, Lucas M, Gómez CL, Rabasa AC, Alcina A, Matesanz F, Alloza I, Antigüedad A, García-Barcina M, Otaegui D, Olascoaga J, Saiz A, Blanco Y, Montalbán X, Vandenbroeck K, Urcelay E.

Mult Scler. 2012 Jul;18(7):959-65. doi: 10.1177/1352458511432741. Epub 2011 Dec 22.

PMID:
22194214
2.

Association of the CBLB gene with multiple sclerosis: new evidence from a replication study in an Italian population.

Corrado L, Bergamaschi L, Barizzone N, Fasano ME, Guerini FR, Salvetti M, Galimberti D, Benedetti MD, Leone M, D'Alfonso S.

J Med Genet. 2011 Mar;48(3):210-1. doi: 10.1136/jmg.2010.081380. Epub 2010 Oct 30.

PMID:
21037273
3.

Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis.

Sanna S, Pitzalis M, Zoledziewska M, Zara I, Sidore C, Murru R, Whalen MB, Busonero F, Maschio A, Costa G, Melis MC, Deidda F, Poddie F, Morelli L, Farina G, Li Y, Dei M, Lai S, Mulas A, Cuccuru G, Porcu E, Liang L, Zavattari P, Moi L, Deriu E, Urru MF, Bajorek M, Satta MA, Cocco E, Ferrigno P, Sotgiu S, Pugliatti M, Traccis S, Angius A, Melis M, Rosati G, Abecasis GR, Uda M, Marrosu MG, Schlessinger D, Cucca F.

Nat Genet. 2010 Jun;42(6):495-7. doi: 10.1038/ng.584. Epub 2010 May 9.

4.

A multiple sclerosis-associated variant of CBLB links genetic risk with type I IFN function.

Stürner KH, Borgmeyer U, Schulze C, Pless O, Martin R.

J Immunol. 2014 Nov 1;193(9):4439-47. doi: 10.4049/jimmunol.1303077. Epub 2014 Sep 26.

5.

The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis.

Begovich AB, Chang M, Caillier SJ, Lew D, Catanese JJ, Wang J, Hauser SL, Oksenberg JR.

Hum Immunol. 2007 Nov;68(11):934-7. Epub 2007 Oct 8.

PMID:
18082575
6.

Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci.

International Multiple Sclerosis Genetics Consortium (IMSGC).

Hum Mol Genet. 2010 Mar 1;19(5):953-62. doi: 10.1093/hmg/ddp542. Epub 2009 Dec 9.

7.

Meta-analysis of the IL23R and IL12B polymorphisms in multiple sclerosis.

Huang J, Yang Y, Zhou F, Liang Z, Kang M, Kuang Y, Li F.

Int J Neurosci. 2016;126(3):205-12. doi: 10.3109/00207454.2015.1007508. Epub 2015 Jun 16.

PMID:
26000455
8.

Resequencing of the IL12B gene in psoriasis patients with the rs6887695/rs3212227 risk genotypes.

Eiris N, Santos-Juanes J, Coto-Segura P, Gómez J, Alvarez V, Morales B, Queiro R, Díaz M, Corao AI, López-Corte K, Coto E.

Cytokine. 2012 Oct;60(1):27-9. doi: 10.1016/j.cyto.2012.05.030. Epub 2012 Jun 26.

PMID:
22739501
9.

An interleukin 12 B single nucleotide polymorphism increases IL-12p40 production and is associated with increased disease susceptibility in patients with relapsing-remitting multiple sclerosis.

Javan MR, Shahraki S, Safa A, Zamani MR, Salmaninejad A, Aslani S.

Neurol Res. 2017 May;39(5):435-441. doi: 10.1080/01616412.2017.1301623. Epub 2017 Mar 9.

PMID:
28276258
10.

Unifying candidate gene and GWAS Approaches in Asthma.

Michel S, Liang L, Depner M, Klopp N, Ruether A, Kumar A, Schedel M, Vogelberg C, von Mutius E, von Berg A, Bufe A, Rietschel E, Heinzmann A, Laub O, Simma B, Frischer T, Genuneit J, Gut IG, Schreiber S, Lathrop M, Illig T, Kabesch M.

PLoS One. 2010 Nov 12;5(11):e13894. doi: 10.1371/journal.pone.0013894.

11.

IL23R and IL12B polymorphisms in Spanish IBD patients: no evidence of interaction.

Márquez A, Mendoza JL, Taxonera C, Díaz-Rubio M, De La Concha EG, Urcelay E, Martínez A.

Inflamm Bowel Dis. 2008 Sep;14(9):1192-6. doi: 10.1002/ibd.20463.

PMID:
18383521
12.

Genetic variants in the IL12B gene are associated with inflammatory bowel diseases in the Korean population.

Moon CM, Shin DJ, Son NH, Shin ES, Hong SP, Kim TI, Kim WH, Cheon JH.

J Gastroenterol Hepatol. 2013 Oct;28(10):1588-94. doi: 10.1111/jgh.12214.

PMID:
23573954
13.

IL12B and IL23R gene SNPs in Japanese psoriasis.

Oka A, Mabuchi T, Ikeda S, Terui T, Haida Y, Ozawa A, Yatsu K, Kulski JK, Inoko H.

Immunogenetics. 2013 Nov;65(11):823-8. doi: 10.1007/s00251-013-0721-x. Epub 2013 Aug 17.

PMID:
23955419
14.

FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis.

Sellebjerg F, Krakauer M, Khademi M, Olsson T, Sørensen PS.

Clin Exp Immunol. 2012 Nov;170(2):149-55. doi: 10.1111/j.1365-2249.2012.04654.x.

15.

Genetic variations in IL6 and IL12B decreasing the risk for psoriasis.

Boca AN, Talamonti M, Galluzzo M, Botti E, Vesa SC, Chimenti S, Buzoianu AD, Costanzo A.

Immunol Lett. 2013 Nov-Dec;156(1-2):127-31. doi: 10.1016/j.imlet.2013.09.028. Epub 2013 Oct 17.

PMID:
24140476
16.

Interaction analysis of the CBLB and CTLA4 genes in type 1 diabetes.

Payne F, Cooper JD, Walker NM, Lam AC, Smink LJ, Nutland S, Stevens HE, Hutchings J, Todd JA.

J Leukoc Biol. 2007 Mar;81(3):581-3. Epub 2007 Jan 5.

PMID:
17209142
17.

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.

Patsopoulos NA; Bayer Pharma MS Genetics Working Group; Steering Committees of Studies Evaluating IFNβ-1b and a CCR1-Antagonist; ANZgene Consortium; GeneMSA; International Multiple Sclerosis Genetics Consortium, Esposito F, Reischl J, Lehr S, Bauer D, Heubach J, Sandbrink R, Pohl C, Edan G, Kappos L, Miller D, Montalbán J, Polman CH, Freedman MS, Hartung HP, Arnason BG, Comi G, Cook S, Filippi M, Goodin DS, Jeffery D, O'Connor P, Ebers GC, Langdon D, Reder AT, Traboulsee A, Zipp F, Schimrigk S, Hillert J, Bahlo M, Booth DR, Broadley S, Brown MA, Browning BL, Browning SR, Butzkueven H, Carroll WM, Chapman C, Foote SJ, Griffiths L, Kermode AG, Kilpatrick TJ, Lechner-Scott J, Marriott M, Mason D, Moscato P, Heard RN, Pender MP, Perreau VM, Perera D, Rubio JP, Scott RJ, Slee M, Stankovich J, Stewart GJ, Taylor BV, Tubridy N, Willoughby E, Wiley J, Matthews P, Boneschi FM, Compston A, Haines J, Hauser SL, McCauley J, Ivinson A, Oksenberg JR, Pericak-Vance M, Sawcer SJ, De Jager PL, Hafler DA, de Bakker PI.

Ann Neurol. 2011 Dec;70(6):897-912. doi: 10.1002/ana.22609. Erratum in: Ann Neurol. 2013 Apr;73(4):561.

18.

Preliminary Study on the Role of TMEM39A Gene in Multiple Sclerosis.

Wagner M, Sobczyński M, Bilińska M, Pokryszko-Dragan A, Cyrul M, Kuśnierczyk P, Jasek M.

J Mol Neurosci. 2017 Jun;62(2):181-187. doi: 10.1007/s12031-017-0921-1. Epub 2017 Apr 25.

19.

Analysis of polymorphisms in RIG-I-like receptor genes in German multiple sclerosis patients.

Varzari A, Bruch K, Deyneko IV, Chan A, Epplen JT, Hoffjan S.

J Neuroimmunol. 2014 Dec 15;277(1-2):140-4. doi: 10.1016/j.jneuroim.2014.09.015. Epub 2014 Sep 28.

PMID:
25288302
20.

Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis.

Capon F, Di Meglio P, Szaub J, Prescott NJ, Dunster C, Baumber L, Timms K, Gutin A, Abkevic V, Burden AD, Lanchbury J, Barker JN, Trembath RC, Nestle FO.

Hum Genet. 2007 Sep;122(2):201-6. Epub 2007 Jun 22.

PMID:
17587057

Supplemental Content

Support Center